Analyst Ratings For NYSE:HAE – Haemonetics (NYSE:HAE)
Today, Jefferies Group raised its price target on NYSE:HAE – Haemonetics (NYSE:HAE) to per share.
Some recent analyst ratings include
- 5/9/2018-Morgan Stanley Reiterated Rating of Overweight ➝ Buy.
- 2/7/2018-Barrington Research Reiterated Rating of Outperform ➝ Outperform.
- 2/7/2018-JMP Securities Reiterated Rating of Outperform.
- 1/2/2018-Raymond James Upgrade from a “Underperform ➝ Market Perform” rating to a “” rating.
- 11/8/2017-Craig Hallum Reiterated Rating of Hold.
- 11/7/2016-BTIG Research Reiterated Rating of Neutral.
- On 4/6/2018 Dan Goldstein, VP, sold 518 with an average share price of $54.65 per share and the total transaction amounting to $28,308.70.
- On 3/6/2018 Jacqueline Scanlan, SVP, sold 114 with an average share price of $72.23 per share and the total transaction amounting to $8,234.22.
- On 3/6/2018 Michelle L. Basil, EVP, sold 389 with an average share price of $72.23 per share and the total transaction amounting to $28,097.47.
- On 1/2/2018 Mark W Kroll, Director, sold 7,118 with an average share price of $63.00 per share and the total transaction amounting to $448,434.00.
- On 12/1/2017 Pedro P Granadillo, Director, sold 7,118 with an average share price of $57.06 per share and the total transaction amounting to $406,153.08.
- On 11/16/2017 Ronald G Gelbman, Director, sold 5,440 with an average share price of $56.69 per share and the total transaction amounting to $308,393.60.
- On 11/14/2017 Willaim P Burke, CFO, sold 13,193 with an average share price of $54.04 per share and the total transaction amounting to $712,949.72.
Recent Trading Activity for NYSE:HAE – Haemonetics (NYSE:HAE)
Shares of NYSE:HAE – Haemonetics closed the previous trading session at 85.13 up +2.58 3.13% with 83.27999877929688 shares trading hands.